Viewing Study NCT00089167


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-23 @ 8:31 PM
Study NCT ID: NCT00089167
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 2004-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module